U.S. Markets closed

New Morgan Stanley GIFT Cures℠ Program to Advance Drug Discovery Research into Life-Saving and Life-Enhancing Cures and Treatments

NEW YORK--(BUSINESS WIRE)--

Morgan Stanley GIFT Cures is a philanthropic collaboration with Harrington Discovery Institute

Morgan Stanley today announced the launch of Morgan Stanley GIFT Cures powered by Harrington Discovery Institute , the first special interest program of The Morgan Stanley Global Impact Funding Trust (Morgan Stanley GIFT) that is dedicated to advancing the development of research discoveries into new cures and treatments for a broad range of diseases. The launch was announced at The Exchange 2019 in New York, a two-day conference, June 4-5, hosted by Morgan Stanley and Social Impact Exchange.

“We are excited to join forces with Harrington Discovery Institute,” said Mandell Crawley, Head of Morgan Stanley Private Wealth Management. “Sadly, there are far too many families around the world that are impacted by a disease that has no cure or meaningful treatment, including many of the most common diseases affecting our society. The Morgan Stanley GIFT Cures program was formed to address unmet medical need by helping to create new medicines.”

Through a competitive application process, Harrington Discovery Institute sources the most promising research from leading academic institutions across the U.S., Canada and the UK that target novel therapeutic approaches in any disease area. The combination of Harrington Discovery Institute and Morgan Stanley GIFT Cures will help provide the catalytic capital, expertise and management needed to connect strategic philanthropists to drug discovery projects and medical breakthroughs with the greatest potential for near-term impact.

“With nearly two decades of experience working with the Firm’s most dedicated philanthropists, Morgan Stanley GIFT recognized that medical philanthropy wasn’t moving the needle for patients and families with diseases despite the generosity of donors around the world,” said Melanie Schnoll Begun, Head of Philanthropy Management. “We are pleased to collaborate with Harrington Discovery Institute to launch Morgan Stanley GIFT Cures, an innovative special interest program Morgan Stanley GIFT created in response to client demands for more concrete results from their philanthropy in the search for cures.”

“Hundreds of millions of people suffer from diseases where cures are not available, yet the knowledge to develop effective treatments actually exists,” explains Dr. Jonathan Stamler, President of Harrington Discovery Institute. “Breakthrough discoveries remain on the shelves of research institutions because the physicians and scientists making discoveries lack the drug development expertise needed to translate their scientific discoveries into new medicines.”

Harrington Discovery Institute was established in 2012 with a $50 million gift from the Harrington Family, medical supply entrepreneurs. The Institute was founded to create a new system for developing breakthrough discoveries into medicines, primarily in answer to two challenges: Why so many promising medical breakthroughs fail to yield life-enhancing and life-saving new drugs, and where financial and other resources should be invested to improve and accelerate success.

Seven years later, Harrington Discovery Institute has become the center of a rapidly growing global initiative to advance the most promising new therapies through the drug development pipeline.

“We are pleased to collaborate with Morgan Stanley GIFT to grow the community of philanthropists who are committed to supporting the development of new medicines. From the start, we knew that strategic partnerships like this would be instrumental in helping expand Harrington Discovery Institute’s portfolio of drugs-in-the-making and increase its impact on human health,” said Ronald Harrington.

The Morgan Stanley GIFT Cures program provides opportunities for philanthropists to augment the impact of their medically-related giving, whether they wish to focus on a specific disease or across a broader spectrum. It is also an opportunity to become part of a donor community committed to creating the next generation of breakthrough medicines, including learning best practices in bringing breakthrough therapies to market and in healthcare giving more broadly.

At launch, the Morgan Stanley GIFT Cures program is funding multiple programs to advance treatment for:

  • Alzheimer’s & Other Neurologic Diseases
  • Cancers
  • Heart failure and Other Cardiovascular Diseases
  • Blindness
  • Bone and Joint Diseases
  • Diabetes
  • Gastrointestinal Diseases
  • All Infectious Diseases
  • All Rare Diseases
  • Asthma and Respiratory Diseases
  • Immune and other Disorders

Morgan Stanley GIFT is an independent 501(c)(3) organization that provides the Firm’s clients access to a donor advised fund, supporting organizations, other planned giving strategies, client events and experiences. Established in 2000; total grants to charities have reached over $1.7 billion since inception. All funds donated to Morgan Stanley GIFT Cures will be managed within the Morgan Stanley GIFT donor advised fund to advance Harrington Discovery Institute’s mission of advancing breakthrough scientific discoveries throughout the U.S. and the UK into cures.

Morgan Stanley Wealth Management, a global leader, provides access to a wide range of products and services to individuals, businesses and institutions, including brokerage and investment advisory services, financial and wealth planning, cash management and lending products and services, annuities and insurance, retirement and trust services.

Morgan Stanley ( MS ) is a leading global financial services firm providing investment banking, securities, wealth management and investment management services. With offices in more than 41 countries, the Firm’s employees serve clients worldwide including corporations, governments, institutions and individuals. For more information about Morgan Stanley, please visit www.morganstanley.com .

The Harrington Discovery Institute at University Hospitals in Cleveland, OH – part of The Harrington Project for Discovery & Development – aims to advance medicine and society by enabling our nation’s most inventive scientists to turn their discoveries into medicines that improve human health. The institute was created in 2012 with a $50 million founding gift from the Harrington family and instantiates the commitment they share with University Hospitals to a Vision for a ‘Better World’. For more information, visit www.harringtondiscovery.org .

©2019 Morgan Stanley Smith Barney LLC. Member SIPC

CRC 2559978 6/2019

Disclosures: This material is for informational purposes only. The information and data herein are believed to be reliable; however, their accuracy and completeness is not guaranteed by Morgan Stanley Smith Barney LLC (“Morgan Stanley”) and providing you with this information is not to be considered a solicitation on our part with respect to the purchase or sale of any securities, investments, strategies or products that may be mentioned. In addition, the information and data referenced is as of the date of the material and subject to change without notice. Past performance is not a guarantee of future results.

Morgan Stanley, its affiliates and Morgan Stanley Financial Advisors and Private Wealth Advisors do not provide tax or legal advice. Clients should consult their tax advisor for matters involving taxation and tax planning and their attorney for matters involving trust and estate planning, charitable giving, philanthropic planning and other legal matters.

University Hospital of Cleveland, OH is a client of Morgan Stanley. It is not known whether the client approves of Morgan Stanley or the advisory services provided. Nothing in this material is intended to imply any other affiliation, sponsorship, endorsement, approval, investigation, verification or monitoring of the Harrington Discovery Institute, University Hospital of Cleveland, OH or any other entity referenced in this material.

The Morgan Stanley Global Impact Funding Trust, Inc. (“Morgan Stanley GIFT, Inc.”) is an organization described in Section 501(c)(3) of the Internal Revenue Code of 1986, as amended. MS Global Impact Funding Trust (“Morgan Stanley GIFT”) is a donor-advised fund. Morgan Stanley provides investment management services to Morgan Stanley GIFT.

While we believe that Morgan Stanley GIFT Cures provides a valuable philanthropic opportunity, contributions to Morgan Stanley GIFT Cures are not appropriate for everyone. Other forms of charitable giving may be more appropriate depending on a donor’s specific situation. Of critical importance to any person considering making a donation to Morgan Stanley GIFT is the fact that any such donation is an irrevocable contribution.

Back office administration provided by RenPSG, an unaffiliated charitable gift administrator.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190604005987/en/